SE7608037L - 2-substituerade oxazolopyridiner - Google Patents

2-substituerade oxazolopyridiner

Info

Publication number
SE7608037L
SE7608037L SE7608037A SE7608037A SE7608037L SE 7608037 L SE7608037 L SE 7608037L SE 7608037 A SE7608037 A SE 7608037A SE 7608037 A SE7608037 A SE 7608037A SE 7608037 L SE7608037 L SE 7608037L
Authority
SE
Sweden
Prior art keywords
compounds
tetrahydronaphthalene
july
amino
alkyl
Prior art date
Application number
SE7608037A
Other languages
English (en)
Other versions
SE431545B (sv
Inventor
N P Jensen
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of SE7608037L publication Critical patent/SE7608037L/sv
Publication of SE431545B publication Critical patent/SE431545B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/73Unsubstituted amino or imino radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/49Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups
    • C07C205/57Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C63/00Compounds having carboxyl groups bound to a carbon atoms of six-membered aromatic rings
    • C07C63/68Compounds having carboxyl groups bound to a carbon atoms of six-membered aromatic rings containing halogen
    • C07C63/72Polycyclic acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE7608037A 1975-07-29 1976-07-14 Forfarande for framstellning av nya 2-substituerade oxazolopyridiner SE431545B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/600,169 US4011326A (en) 1975-07-29 1975-07-29 2-Substituted oxazolo[4,5-b]pyridine anti-inflammatory agents

Publications (2)

Publication Number Publication Date
SE7608037L true SE7608037L (sv) 1977-01-30
SE431545B SE431545B (sv) 1984-02-13

Family

ID=24402575

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7608037A SE431545B (sv) 1975-07-29 1976-07-14 Forfarande for framstellning av nya 2-substituerade oxazolopyridiner

Country Status (14)

Country Link
US (1) US4011326A (sv)
JP (1) JPS6037116B2 (sv)
AU (1) AU505159B2 (sv)
BE (1) BE844577A (sv)
CH (1) CH603661A5 (sv)
DE (1) DE2633905A1 (sv)
DK (1) DK320276A (sv)
ES (1) ES450245A1 (sv)
FR (1) FR2319354A1 (sv)
GB (1) GB1497985A (sv)
HU (1) HU172167B (sv)
NL (1) NL7607794A (sv)
SE (1) SE431545B (sv)
ZA (1) ZA764527B (sv)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH085368Y2 (ja) * 1987-03-05 1996-02-14 日産自動車株式会社 内燃機関のコネクティングロッド
JP2001503443A (ja) * 1996-11-11 2001-03-13 ビイク グルデン ロンベルク ヒエーミツシエ フアブリーク ゲゼルシヤフト ミツト ベシユレンクテル ハフツング 新規イミダゾ―及びオキサゾロピリジン
ES2264482T3 (es) 2001-05-15 2007-01-01 F. Hoffmann-La Roche Ag Derivados de oxazol sustituidos por acido carboxilico para uso como activadores de ppar-alfa y gamma en el tratamiento de diabetes.
EP1554572B1 (en) 2001-07-25 2009-10-14 Raptor Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
DE60316290T2 (de) * 2002-07-03 2008-06-12 F. Hoffmann-La Roche Ag Oxazolderivate und deren verwendung als insulinsensibilisatoren
DK1537091T3 (da) * 2002-08-30 2010-11-08 Hoffmann La Roche Hidtil ukendte 2-arylthiazolforbindelser som PPAR alpha- og PPAR gamma-agonister
JP4286782B2 (ja) * 2002-09-12 2009-07-01 エフ.ホフマン−ラ ロシュ アーゲー 糖尿病の治療に有用な、pparアゴニストとしてのn−置換−1h−インドール−5−プロピオン酸化合物
DE60323130D1 (de) * 2002-11-25 2008-10-02 Hoffmann La Roche Indolderivaten
EP3827747A1 (en) 2005-04-28 2021-06-02 Otsuka Pharmaceutical Co., Ltd. Pharma-informatics system
EP2063905B1 (en) 2006-09-18 2014-07-30 Raptor Pharmaceutical Inc Treatment of liver disorders by administration of receptor-associated protein (rap)-conjugates
NZ616673A (en) 2009-02-20 2014-08-29 To Bbb Holding B V Glutathione-based drug delivery system
ES2942923T3 (es) 2009-05-06 2023-06-07 Laboratory Skin Care Inc Composiciones de administración dérmica que comprenden complejos de agente activo-partículas de fosfato de calcio y métodos de uso de las mismas
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3935195A (en) * 1969-04-28 1976-01-27 Sterling Drug Inc. 4,4'-Stilbenebis-pyridooxazoles and related optical brighteners and polymeric compositions brightened thereby
FR2148362A1 (en) * 1971-08-11 1973-03-23 Ferlux 2-amino-(4,5-b)-oxazolopyridine cpds - with analgesic,anti-inflammato anticonvulsant,muscle relaxant and diuretic activity
AR208500A1 (es) * 1972-06-14 1977-02-15 Merck & Co Inc Procedimiento para la preparacion de derivados de oxazolo(4,5-b)-piridinas

Also Published As

Publication number Publication date
DE2633905A1 (de) 1977-02-17
FR2319354A1 (fr) 1977-02-25
AU505159B2 (en) 1979-11-08
CH603661A5 (sv) 1978-08-31
ES450245A1 (es) 1979-05-16
JPS5217495A (en) 1977-02-09
HU172167B (hu) 1978-06-28
NL7607794A (nl) 1977-02-01
AU1605276A (en) 1978-01-26
JPS6037116B2 (ja) 1985-08-24
DK320276A (da) 1977-01-30
SE431545B (sv) 1984-02-13
FR2319354B1 (sv) 1979-07-20
US4011326A (en) 1977-03-08
GB1497985A (en) 1978-01-12
ZA764527B (en) 1978-03-29
BE844577A (fr) 1977-01-28

Similar Documents

Publication Publication Date Title
SE7608037L (sv) 2-substituerade oxazolopyridiner
SE7613651L (sv) Sett att framstella fenylettiksyraderivat
GB1488601A (en) Pyrazolopyridopyrimidine derivatives
SE7705637L (sv) Forfarande for framstellning av dibensoxepinderivat med terapeutisk verkan
GB1285400A (en) Esters of substituted anthranilic acid
ES454085A1 (es) Procedimiento para la preparacion de n-(r-tetrahidrofurfu- ril)-noroximorfona y n-(s-tetrahidrofurfuril)-noroximorfona nuevas.
GB1357449A (en) Furoquinolinecarboxylic acid derivatives
SE7602840L (sv) Forfarande for framstellning av nikotinsyraamid
SE8305917D0 (sv) Mellanprodukter for anvendning vid framstellning av hexahydro-gamma-karbolinforeningar
GB1494773A (en) Hydroxyphenylalkanoic acids and lactones thereof
ES442886A1 (es) Un procedimiento para la preparacion de una nueva d-6-metil-ergolina 2-sustituida y 8-sustituida.
GB1529251A (en) 9,10-dihydroergopeptines
JPS549240A (en) New derivative of phenylglycolic acid, its preparation and analgesic and antiinflammatory agent contining it as effective component
GB1505525A (en) Pyridopyrimidines
FI55037C (fi) Foerfarande foer framstaellning av d-homosteroider med endokrin verkan
GB1503626A (en) Substituted piperazine derivative its preparation and compositions containing it
JPS53121787A (en) Preparation of oxazolinoazetidinylpentenoic acid derivatives
JPS532449A (en) Preparation of 2-substituted propionic acid derivatives
FR2395250A1 (fr) Derives des acides amino- du guanidino-phenylpropioniques
JPS5273842A (en) Preparation of 2,2-dimethyl-3-)alpha-hydroxy-alphe-trihalogenomethylme thyl) -cyclopropane carboxylic acid derivatives
GB1477996A (en) Quinolizine derivatives and their preparation
JPS5283411A (en) Preparation of 3,3-dimethyl-4-pentenoic acid and its derivatives
FR2386540A1 (fr) Derives d'acides furoyl- ou thenoyl- naphtyloxyalkylcarboxyliques, leur preparation et leur utilisation comme medicaments
ES343389A1 (es) Un procedimiento para la preparacion de acidos ariloxiace- ticos.
ES450125A1 (es) Procedimiento para la preparacion de acidos -(6,11-dihidro- 11-oxodibenz (b,e) oxepin-2-il)-alcanoicos.

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7608037-3

Effective date: 19920210

Format of ref document f/p: F